Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota

Cited by (1,041)

Items 601–700 of 1,041

1. Anti-breast Cancer Enhancement of a Polysaccharide From Spore of Ganoderma lucidum With Paclitaxel: Suppression on Tumor Metabolism With Gut Microbiota Reshaping
   Jiyan Su, Dan Li, Qianjun Chen, Muxia Li, Lu Su, Ting L. Luo, Danling Liang, Guoxiao Lai, Ou Shuai, Chunwei Jiao et al. · 2018 · Frontiers in Microbiology
2. Immunotherapy in Non–Small-Cell Lung Cancer Patients With Performance Status 2: Clinical Decision Making With Scant Evidence
   Antonio Passaro, Gianluca Spitaleri, Bishal Gyawali, Filippo de Marinis · 2019 · Journal of Clinical Oncology
3. Fecal Microbial Transplantation for Diseases Beyond Recurrent Clostridium Difficile Infection
   Geert D’Haens, Christian Jobin · 2019 · Gastroenterology
4. Balancing cancer immunotherapy and immune-related adverse events: The emerging role of regulatory T cells
   Themis Alissafi, Aikaterini Hatzioannou, A.I. Legaki, Athina Varveri, Panayotis Verginis · 2019 · Journal of Autoimmunity
5. Mushroom polysaccharides and jiaogulan saponins exert cancer preventive effects by shaping the gut microbiota and microenvironment in Apc mice
   Imran Khan, Guoxin Huang, Xiaoang Li, Weilin Liao, Wai Kit Leong, Wenrui Xia, Xiqing Bian, Jian‐Lin Wu, W.L. Wendy Hsiao · 2019 · Pharmacological Research
6. Intestinal microbiota: a new force in cancer immunotherapy
   Zhujiang Dai, Jingqiu Zhang, Qi Wu, Huiwen Fang, Chunfeng Shi, Zhen Li, Chaobiao Lin, Dong Tang, Daorong Wang · 2020 · Cell Communication and Signaling
7. Genomic insights into head and neck cancer
   Tim N. Beck, Erica A. Golemis · 2016 · Cancers of the Head & Neck
8. Microbiota—myeloid cell crosstalk beyond the gut
   Sayeh Gorjifard, Romina S. Goldszmid · 2016 · Journal of Leukocyte Biology
9. The Gut–Brain Axis, Paving the Way to Brain Cancer
   Ruty Mehrian‐Shai, Juergen K. V. Reichardt, Curtis C. Harris, Amos Toren · 2019 · Trends in cancer
10. The spontaneous remission of cancer: Current insights and therapeutic significance
    Gudapureddy Radha, Manu Lopus · 2021 · Translational Oncology
11. The Role of Bioactive Compounds in Natural Products Extracted from Plants in Cancer Treatment and Their Mechanisms Related to Anticancer Effects
    Meng Yuan, Guoqing Zhang, Weijun Bai, Xin Han, Chan Li, Siman Bian · 2022 · Oxidative Medicine and Cellular Longevity
12. The gut microbiota in breast cancer development and treatment: The good, the bad, and the useful!
    Deeptashree Nandi, Sheetal Parida, Dipali Sharma · 2023 · Gut Microbes
13. Oral delivery of bacteria: Basic principles and biomedical applications
    Shuqi Li, Weiqian Jiang, Chunxiong Zheng, Dan Shao, Yilun Liu, Shuqiang Huang, Jing Han, Jianxun Ding, Yu Tao, Mingqiang Li · 2020 · Journal of Controlled Release
14. Targeting MDSC for Immune-Checkpoint Blockade in Cancer Immunotherapy: Current Progress and New Prospects
    Tianhang Li, Tianyao Liu, Wenjie Zhu, Shangxun Xie, Zihan Zhao, Baofu Feng, Hongqian Guo, Rong Yang · 2021 · Clinical Medicine Insights Oncology
15. Boosting Checkpoint Immunotherapy with Biomaterials
    Lujie Liu, Yuanwei Pan, Chenchen Zhao, Peng Huang, Xiaoyuan Shawn Chen, Lang Rao · 2023 · ACS Nano
16. Turning cold tumors into hot tumors to ignite immunotherapy
    Yuan‐Tong Liu, Yunlong Wang, Shuo Wang, Jiajun Li, Wei A. He, Xin-Juan Fan, Xiang‐Bo Wan · 2025 · Molecular Cancer
17. Dysbiosis Across Multiple Body Sites in Critically Ill Adult Surgical Patients
    Andrew Yeh, Matthew Brian Rogers, Brian Firek, Matthew D. Neal, Brian Scott Zuckerbraun, Michael J. Morowitz · 2016 · Shock
18. The salivary microbiome as an indicator of carcinogenesis in patients with oropharyngeal squamous cell carcinoma: A pilot study
    Axel Wolf, Christine Moissl‐Eichinger, Alexandra Perras, Kaisa Koskinen, Peter Valentin Tomazic, Dietmar Thurnher · 2017 · Scientific Reports
19. Role of the microbiome in occurrence, development and treatment of pancreatic cancer
    Yi‐Cheng Wang, Gang Yang, Lei You, Jinshou Yang, Mengyu Feng, Jiangdong Qiu, Fangyu Zhao, Yueze Liu, Zhe Cao, Lianfang Zheng et al. · 2019 · Molecular Cancer
20. Probiotics in microbiome ecological balance providing a therapeutic window against cancer
    Nirmala Sehrawat, Mukesh Kumar Yadav, Manoj Pratap Singh, Vikas Kumar, Varruchi Sharma, Anil Kumar Sharma · 2020 · Seminars in Cancer Biology
21. Gut microbiota reshapes cancer immunotherapy efficacy: Mechanisms and therapeutic strategies
    Jindong Xie, Manqing Liu, Xinpei Deng, Yuhui Tang, Shaoquan Zheng, Xueqi Ou, Hailin Tang, Xiaoming Xie, Minqing Wu, Yutian Zou · 2024 · iMeta
22. Impact of antibiotic therapy on the development and response to treatment of immune checkpoint inhibitor-mediated diarrhea and colitis
    Hamzah Abu‐Sbeih, Lauren Nicholas Herrera, Tenglong Tang, Mehmet Altan, Anne‐Marie Chaftari, Pablo C. Okhuysen, Robert R. Jenq, Yinghong Wang · 2019 · Journal for ImmunoTherapy of Cancer
23. Progress and Challenges of Predictive Biomarkers for Immune Checkpoint Blockade
    Yanna Lei, Xiaoying Li, Qian Huang, Xiufeng Zheng, Ming Liu · 2021 · Frontiers in Oncology
24. The emerging role of the small intestinal microbiota in human health and disease
    Renate A.A.A. Ruigrok, Rinse Karel Weersma, Arnau Vich Vila · 2023 · Gut Microbes
25. Gut microbiome and lipid metabolism
    Zheng Wang, Debby P.Y. Koonen, Marten H. Hofker, Jingyuan Fu · 2016 · Current Opinion in Lipidology
26. Current modalities in cancer immunotherapy: Immunomodulatory antibodies, CARs and vaccines
    Jason J. Lohmueller, Olivera J. Finn · 2017 · Pharmacology & Therapeutics
27. Immune Checkpoint Inhibitors in Hepatocellular Cancer: Current Understanding on Mechanisms of Resistance and Biomarkers of Response to Treatment
    Amblessed E. Onuma, Hongji Zhang, Hai Huang, Terence Marques Williams, Anne M. Noonan, Allan Tsung · 2020 · Gene Expression
28. Bifidobacterium Strain-Specific Enhances the Efficacy of Cancer Therapeutics in Tumor-Bearing Mice
    Youngmin Yoon, Gihyeon Kim, Bu‐Nam Jeon, Sungsoon Fang, Hansoo Park · 2021 · Cancers
29. Microbiota-driven mechanisms at different stages of cancer development
    Elena Ivleva, Sergei I. Grivennikov · 2022 · Neoplasia
30. Mucosal-associated invariant T cells for cancer immunotherapy
    Yan-Ruide Li, Kuangyi Zhou, Matthew Wilson, Adam B. Kramer, Yichen Zhu, Niels Dawson, Lili Yang · 2022 · Molecular Therapy
31. The impact of the intestinal microbiota in therapeutic responses against cancer
    Anne‐Gaëlle Goubet, Romain Daillère, Bertrand Routy, Lisa Derosa, Paula M. Roberti, Laurence Zitvogel · 2018 · Comptes Rendus Biologies
32. Applications of Metabolomics in Cancer Studies
    Emily Grace Armitage, Michał Ciborowski · 2017 · Advances in experimental medicine and biology
33. Microbiota–drug interactions: Impact on metabolism and efficacy of therapeutics
    Ellen M. Wilkinson, Zehra Esra Ilhan, Melissa M. Herbst‐Kralovetz · 2018 · Maturitas
34. The Microbiome and Tuberculosis: Early Evidence for Cross Talk
    Sivaranjani Namasivayam, Alan Sher, Michael S. Glickman, Matthew F. Wipperman · 2018 · mBio
35. Harnessing the innate immune system and local immunological microenvironment to treat colorectal cancer
    Jakob Nikolas Kather, Niels Halama · 2019 · British Journal of Cancer
36. C-reactive protein as an early marker of immune-related adverse events
    Amir-Reza Abolhassani, Gerold Schuler, Michael Constantin Kirchberger, Lucie Heinzerling · 2019 · Journal of Cancer Research and Clinical Oncology
37. Resistance to PD-L1/PD-1 Blockade Immunotherapy. A Tumor-Intrinsic or Tumor-Extrinsic Phenomenon?
    Luisa Chocarro, Miren Zuazo, Hugo Arasanz, Ana Bocanegra, Carlos Hernandez, Gonzalo Fernández, María Jesús García-Granda, Ester Blanco, Ruth Vera, Grazyna T. Kochan et al. · 2020 · Frontiers in Pharmacology
38. Resistance to immune checkpoint inhibitors in non-small cell lung cancer: biomarkers and therapeutic strategies
    Robert John Walsh, Ross Andrew Soo · 2020 · Therapeutic Advances in Medical Oncology
39. Nano-immunotherapy: Unique mechanisms of nanomaterials in synergizing cancer immunotherapy
    Quan Liu, Yanhong Duo, Jianye Fu, Meng Qiu, Zhe Sun, Dickson Adah, Jianlong Kang, Zhongjian Xie, Taojian Fan, Shiyun Bao et al. · 2020 · Nano Today
40. Gut Microbiome in Colorectal Cancer: Clinical Diagnosis and Treatment
    Yali Liu, Harry Cheuk-Hay Lau, Wing Yin Cheng, Jun Qing Yu · 2022 · Genomics Proteomics & Bioinformatics
41. Fecal microbiota transplantation plus immunotherapy in non-small cell lung cancer and melanoma: the phase 2 FMT-LUMINate trial
    Sreya Duttagupta, Meriem Messaoudene, Sebastian Hunter, Antoine Desîlets, Rahima Jamal, Catalin Liviu Dragos Mihalcioiu, Wiam Belkaïd, Nicolas Marcoux, Marine Fidelle, Déborah Suissa et al. · 2026 · Nature Medicine
42. Glutamine promotes intestinal SIgA secretion through intestinal microbiota and IL‐13
    Miaomiao Wu, Hao Xiao, Gang Liu, Shuai Chen, Bie Tan, Wenkai Ren, Fuller W. Bazer, Guoyao Wu, Yulong Yin · 2016 · Molecular Nutrition & Food Research
43. Immune checkpoint inhibitors and tuberculosis: an old disease in a new context
    Ewan Andrew Langan, Victoria Grätz, Judith Allerheiligen, Detlef Zillikens, Jan Rupp, Patrick Andres Maximilian Terheyden · 2020 · The Lancet Oncology
44. Time to dissect the autoimmune etiology of cancer antibody immunotherapy
    Michael Lawrence Dougan, Massimo Pietropaolo · 2020 · Journal of Clinical Investigation
45. The Crosstalk between Microbiome and Immune Response in Gastric Cancer
    Rihab Nasr, Ali I. Shamseddine, Deborah Mukherji, Farah J. Nassar, Sally Naji Temraz · 2020 · International Journal of Molecular Sciences
46. Microbiome diurnal rhythmicity and its impact on host physiology and disease risk
    Samuel Philip Nobs, Timur Tuganbaev, Eran Elinav · 2019 · EMBO Reports
47. Impact of Concomitant Medication Administered at the Time of Initiation of Nivolumab Therapy on Outcome in Non-small Cell Lung Cancer
    Martin Svatoň, Milada Zemanová, Petra Zemanová, Juraj Kultan, Ondřej Fischer, Jana Skřičková, Lenka Jakubíková, Markéta Černovská, Michal Hrnčiarik, MICHAL JIROUSEK et al. · 2020 · Anticancer Research
48. Host immunity modulates the efficacy of microbiota transplantation for treatment of Clostridioides difficile infection
    Eric R. Littmann, Jung‐Jin Lee, Joshua E. Denny, Zahidul Alam, Jeffrey R. Maslanka, Isma Zarin, Rina Matsuda, Rebecca A. Carter, Bože Sušac, Miriam Saffern et al. · 2021 · Nature Communications
49. Cancer as microenvironmental, systemic and environmental diseases: opportunity for transdisciplinary microbiomics science
    Kentaro Inamura, Tsuyoshi Hamada, Susan Bullman, Tomotaka Ugai, Shinichi Yachida, Shuji Ogino · 2022 · Gut
50. Extracellular vesicles of the Gram-positive gut symbiont Bifidobacterium longum induce immune-modulatory, anti-inflammatory effects
    Noa Mandelbaum, Lihan Zhang, Shaqed Carasso, Tamar Ziv, Sapir Lifshiz‐Simon, Irina Davidovich, Ishai Luz, Elliot M. Berinstein, Tal Gefen, Tomer Cooks et al. · 2023 · npj Biofilms and Microbiomes
51. The role of microbiota in cancer therapy
    Ernesto Peréz-Chanona, Giorgio Trinchieri · 2016 · Current Opinion in Immunology
52. Melanoma and microbiota: Current understanding and future directions
    Routy, Bertrand, Jackson, Tanisha, Mählmann, Laura, Baumgartner, Christina K., Blaser, Martin, Byrd, Allyson, Corvaia, Nathalie, Couts, Kasey, Davar, Diwakar, Derosa, Lisa et al. · 2024 · Cancer Cell
53. Gut Microbiota-Immune System Crosstalk and Pancreatic Disorders
    Danilo Pagliari, Angela Saviano, Estelle E. Newton, Michele Serricchio, Antonio Dal Lago, A. Gasbarrini, Rossella Cianci · 2018 · Mediators of Inflammation
54. Gut microbiota, chemotherapy and the host: the influence of the gut microbiota on cancer treatment
    Anna Louise Pouncey, Alasdair James Scott, James Leslie Alexander, Julian Roberto Marchesi, James K. Kinross · 2018 · ecancermedicalscience
55. The gut microbiome in tuberculosis susceptibility and treatment response: guilty or not guilty?
    Osagie A. Eribo, Nelita du Plessis, Mumin Ozturk, Reto Guler, Gerhard Walzl, Novel N. Chegou · 2019 · Cellular and Molecular Life Sciences
56. Improving Cancer Immunotherapy Outcomes Using Biomaterials
    Shuangqian Yan, Zichao Luo, Zhenglin Li, Yu Wang, Jun Tao, Changyang Gong, Xiaogang Liu · 2020 · Angewandte Chemie International Edition
57. Effects of microbiota on anticancer drugs: Current knowledge and potential applications
    Jiayuan Huang, Wenting Liu, Wanying Kang, Yulong He, Ruifu Yang, Xiangyu Mou, Wenjing Zhao · 2022 · EBioMedicine
58. Next‐Generation Probiotics: Microflora Intervention to Human Diseases
    Huanchang Zhang, Yunfeng Duan, Feng Cai, Demin Cao, Lei Wang, Zhenyi Qiao, Qing Hong, Nan Li, Yuanrong Zheng, Miya Su et al. · 2022 · BioMed Research International
59. The human microbiome and cancer: a diagnostic and therapeutic perspective
    Shruthi Kandalai, Huapeng Li, Nan Zhang, Haidong Peng, Qingfei Zheng · 2023 · Cancer Biology & Therapy
60. Immune-Related Adverse Events Due to Cancer Immunotherapy: Immune Mechanisms and Clinical Manifestations
    Silvia Casagrande, Giulia Boscato Sopetto, Giovanni Bertalot, Roberto Bortolotti, Vito Racanelli, Orazio Caffo, Bruno Giometto, Alvise Berti, Antonello Veccia · 2024 · Cancers
61. Shaping the Immune Landscape in Cancer by Galectin-Driven Regulatory Pathways
    Gabriel A. Rabinovich, Jose Ramon Conejo-Garcia · 2016 · Journal of Molecular Biology
62. Adapting Cancer Immunotherapy Models for the Real World
    Lauryn E. Klevorn, Ryan M. Teague · 2016 · Trends in Immunology
63. Impact of antibiotic treatment on immune-checkpoint blockade efficacy in advanced non-squamous non-small cell lung cancer
    Florian Huemer, Gabriel Rinnerthaler, Theresa Westphal, Hubert Hackl, Georg Hutarew, Simon Peter Gampenrieder, Lukas Weiß, Richard Greil · 2018 · Oncotarget
64. Mechanisms of gastrointestinal microflora on drug metabolism in clinical practice
    Chaonan Sun, Ling Chen, Zhu Shen · 2019 · Saudi Pharmaceutical Journal
65. The Resistance Mechanisms of Lung Cancer Immunotherapy
    Fen Wang, Shubin Wang, Qing Hua Zhou · 2020 · Frontiers in Oncology
66. Cancer Immunotherapies: From Efficacy to Resistance Mechanisms – Not Only Checkpoint Matters
    Shuyue Wang, Kun Xie, Tengfei Liu · 2021 · Frontiers in Immunology
67. Probiotics-mediated suppression of cancer
    Stephanie S.Y. So, Murphy Lam Yim Wan, Hani S El-Nezami · 2016 · Current Opinion in Oncology
68. Gut microbial dysbiosis associates hepatocellular carcinoma via the gut-liver axis
    Jianwen Jiang, Xinhua Chen, Zhigang Ren, Shusen Zheng · 2018 · Hepatobiliary & pancreatic diseases international
69. The gut microbiome as a target in cancer immunotherapy: opportunities and challenges for drug development
    Arielle Elkrief, Reilly Pidgeon, Saman Maleki Vareki, Meriem Messaoudene, Bastien Castagner, Bertrand Routy · 2025 · Nature Reviews Drug Discovery
70. Emerging biomarkers for immune checkpoint inhibition in lung cancer
    George Cyriac, Leena Gandhi · 2018 · Seminars in Cancer Biology
71. Reciprocal Interactions Between Gut Microbiota and Host Social Behavior
    Emmanuelle Münger, Augusto Jacobo Montiel-Castro, Wolfgang Langhans, Gustavo Pacheco‐López · 2018 · Frontiers in Integrative Neuroscience
72. Gut Microbiota Manipulation as a Tool for Colorectal Cancer Management: Recent Advances in Its Use for Therapeutic Purposes
    Federica Perillo, Chiara Amoroso, Francesco Strati, Maria Rita Giuffrè, Angélica Díaz‐Basabe, Georgia Lattanzi, Federica Facciotti · 2020 · International Journal of Molecular Sciences
73. Thermal ablation in non-small cell lung cancer: a review of treatment modalities and the evidence for combination with immune checkpoint inhibitors
    Kanishka Rangamuwa, Tracy Leong, Clare E. Weeden, Marie-Liesse Asselin-Labat, Steven Bozinovski, Michael Christie, Tom John, Phillip N. Antippa, Louis B. Irving, Daniel Steinfort · 2021 · Translational Lung Cancer Research
74. Gut Microbiota Modulation in the Context of Immune-Related Aspects of Lactobacillus spp. and Bifidobacterium spp. in Gastrointestinal Cancers
    Karolina Kaźmierczak-Siedlecka, Giandomenico Roviello, Martina Catalano, Karol Połom · 2021 · Nutrients
75. Gut microbiome composition can predict the response to nivolumab in advanced hepatocellular carcinoma patients
    Min-Woo Chung, Moon-Ju Kim, Eun Jeong Won, Yu Jeong Lee, Yong-Woon Yun, Sung Bum Cho, Young‐Eun Joo, Jun‐Eul Hwang, Woo Kyun Bae, Ik‐Joo Chung et al. · 2021 · World Journal of Gastroenterology
76. Clinical Trials Investigating Immune Checkpoint Blockade in Glioblastoma
    Russell Maxwell, Christopher Mitchell Jackson, Michael K. Lim · 2017 · Current Treatment Options in Oncology
77. Gut microbiota: implications for radiotherapy response and radiotherapy-induced mucositis
    Ghanyah H. Al-Qadami, Ysabella Z. A. Van Sebille, Hien V. Le, Joanne M. Bowen · 2019 · Expert Review of Gastroenterology & Hepatology
78. Circadian Influences of Diet on the Microbiome and Immunity
    Danping Zheng, Karina Ratiner, Eran Elinav · 2020 · Trends in Immunology
79. The Impact of Beta Blockers on Survival Outcomes in Patients With Non–small-cell Lung Cancer Treated With Immune Checkpoint Inhibitors
    Michael S. Oh, Alex Guzner, Derek Alan Wainwright, Nisha Anjali Mohindra, Young Kwang Chae, Amir Behdad, Victoria Meucci Villaflor · 2020 · Clinical Lung Cancer
80. The gut microbiota mediates protective immunity against tuberculosis via modulation of lncRNA
    Fang Yang, Yi Yang, Lingming Chen, Zhiyi Zhang, Linna Liu, Chunmin Zhang, Qiongdan Mai, Zixu Chen, Zixu Chen, Tao Lin et al. · 2022 · Gut Microbes
81. The Influence of Nutrition on Intestinal Permeability and the Microbiome in Health and Disease
    Orsolya Inczefi, Péter Bacsúr, Tamás Resál, Csilla Keresztes, Tamás Molnár · 2022 · Frontiers in Nutrition
82. Deciphering T-cell exhaustion in the tumor microenvironment: paving the way for innovative solid tumor therapies
    Reshmi Nair, Veena Somasundaram, Anshu Kuriakose, Shiv Ram Krishn, David Raben, Rachel L. Salazar, Pradip Nair · 2025 · Frontiers in Immunology
83. Glutamine-Induced Secretion of Intestinal Secretory Immunoglobulin A: A Mechanistic Perspective
    Wenkai Ren, Kai Wang, Jie Yin, Shuai Chen, Gang Liu, Bie Tan, Guoyao Wu, Fuller W. Bazer, Yuanyi Peng, Yulong Yin · 2016 · Frontiers in Immunology
84. Immune system and intestinal microbiota determine efficacy of androgen deprivation therapy against prostate cancer
    Terrisse, Safae, Goubet, Anne-Gaelle, Ueda, Kousuke, Thomas, Andrew Maltez, Quiniou, Valentin, Thelemaque, Cassandra, Dunsmore, Garett, Clave, Emmanuel, Gamat-Huber, Melissa, Yonekura, Satoru et al. · 2022 · Journal for ImmunoTherapy of Cancer
85. Advances in Anti-Cancer Immunotherapy: Car-T Cell, Checkpoint Inhibitors, Dendritic Cell Vaccines, and Oncolytic Viruses, and Emerging Cellular and Molecular Targets
    Emilie L. Alard, Aura-Bianca Butnariu, Marta Grillo, Charlotte Kirkham, Dmitry Aleksandrovich Zinovkin, Louise J Newnham, Jenna Macciochi, Md Zahidul Islam Pranjol · 2020 · Cancers
86. State of the Art in the Culture of the Human Microbiota: New Interests and Strategies
    Maryam Tidjani Alou, Sabrina Naud, S. Khelaifia, Marion Bonnet, Jean‐Christophe Lagier, Didier Raoult · 2020 · Clinical Microbiology Reviews
87. The Role of Microbiota in Gastrointestinal Cancer and Cancer Treatment: Chance or Curse?
    Annemieke Smet, Juozas Kupčinskas, Alexander Link, Georgina Louise Hold, Jan Bornschein · 2021 · Cellular and Molecular Gastroenterology and Hepatology
88. The antitumour effects of caloric restriction are mediated by the gut microbiome
    Mao, Yu-Qin, Huang, Jia-Ting, Zhang, Shi-Long, Kong, Chao, Li, Zhan-Ming, Jing, Hui, Chen, Hui-Ling, Kong, Chao-Yue, Huang, Sheng-Hui, Cai, Pei-Ran et al. · 2023 · Nature Metabolism
89. Immunology of bile acids regulated receptors
    Stefano Fiorucci, Silvia Marchianò, Ginevra Urbani, Cristina Di Giorgio, Eleonora Distrutti, Angela Zampella, Michele Biagioli · 2024 · Progress in Lipid Research
90. A gut-on-a-chip incorporating human faecal samples and peristalsis predicts responses to immune checkpoint inhibitors for melanoma
    Mattia Ballerini, Serena Galié, Punit Tyagi, Carlotta Catozzi, Hariam Raji, Amir Nabinejad, Angeli D.G. Macandog, Alessandro Cordiale, Bianca Ionela Slivinschi, Karol K. Kugiejko et al. · 2025 · Nature Biomedical Engineering
91. The microbiome in cancer
    Anqi Lin, Minying Xiong, Aimin Jiang, Li‐Hua Huang, Hank Z. H. Wong, Suyin Feng, Chunyan Zhang, Haijun Yu, Li Chen, Hao Chi et al. · 2025 · iMeta
92. Gut microbial species and metabolic pathways associated with response to treatment with immune checkpoint inhibitors in metastatic melanoma
    Wind, Thijs T., Gacesa, Ranko, Vich Vila, Arnau, de Haan, Jacco J., Jalving, Mathilde, Weersma, Rinse K., Hospers, Geke A.P. · 2020 · Melanoma Research
93. Partially exhausted tumor-infiltrating lymphocytes predict response to combination immunotherapy
    Kimberly Leticia Loo, Katy K. Tsai, Kelly M. Mahuron, Jacqueline Liu, Mariela L. Pauli, Priscila Muñoz Sandoval, Adi Nosrati, James Lee, Lawrence Chen, Jimmy J. Hwang et al. · 2017 · JCI Insight
94. Adjunctive fecal microbiota transplantation in supportive oncology: Emerging indications and considerations in immunocompromised patients
    Hannah R. Wardill, Kate R. Secombe, Robert Venning Bryant, Mette D. Hazenberg, Samuel Paul Costello · 2019 · EBioMedicine
95. The Clinical Link between Human Intestinal Microbiota and Systemic Cancer Therapy
    Romy Aarnoutse, Janine Ziemons, John Penders, Sander S. Rensen, Judith de Vos‐Geelen, Marjolein L. Smidt · 2019 · International Journal of Molecular Sciences
96. Impact of antibiotic use and other concomitant medications on the efficacy of immune checkpoint inhibitors in patients with advanced cancer
    Araceli Iglesias-Santamaría · 2020 · Clinical & Translational Oncology
97. The Value of PD-L1 Expression as Predictive Biomarker in Metastatic Renal Cell Carcinoma Patients: A Meta-Analysis of Randomized Clinical Trials
    Alberto Carretero-González, David Lora, Isabel Martín-Sobrino, Irene Sáez Sanz, Maria Teresa Bourlon, Urbano Anido Herranz, Nieves Martínez Chanzá, Daniel Castellano, Guillermo de Velasco · 2020 · Cancers
98. The Tumor Microenvironment Factors That Promote Resistance to Immune Checkpoint Blockade Therapy
    Bonnie L. Russell, Selisha Ann Sooklal, Sibusiso Tebogo Malindisa, Lembelani Jonathan Daka, Monde McMillan Ntwasa · 2021 · Frontiers in Oncology
99. Antibiotic-induced disturbances of the gut microbiota result in accelerated breast tumor growth
    Alastair M. McKee, Benjamin M. Kirkup, Matthew Madgwick, Wesley J. Fowler, Christopher A. Price, Sally A. Dreger, Rebecca Ansorge, Kate A. Makin, Shabhonam Caim, Gwénaëlle Le Gall et al. · 2021 · iScience
100. Persistent Gut Microbial Dysbiosis in Children with Acute Lymphoblastic Leukemia (ALL) During Chemotherapy
     Seesandra V. Rajagopala, Harinder Singh, Yanbao Yu, Keri B. Zabokrtsky, Manolito Torralba, Kelvin Jens Moncera, Bryan C. Frank, Rembert Pieper, Leonard S. Sender, Karen E. Nelson · 2019 · Microbial Ecology